Detalhe da pesquisa
1.
Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approach.
Rheumatology (Oxford)
; 62(11): 3715-3723, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869684
2.
Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sjögren's syndrome.
RMD Open
; 9(2)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230761
3.
Use of the NEO strategy (Nucleophilic addition/Epoxide Opening) for the synthesis of a new C-galactoside ester analogue of KRN 7000.
Bioorg Med Chem Lett
; 21(8): 2510-4, 2011 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21392982
4.
The stimulating adventure of KRN 7000.
Org Biomol Chem
; 9(9): 3080-104, 2011 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21394364
5.
High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease.
Front Immunol
; 12: 767099, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34899718
6.
Rituximab treatment overcomes reduction of regulatory iNKT cells in patients with rheumatoid arthritis.
Clin Immunol
; 134(3): 331-9, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20022305
7.
Diminution of Circulating CD4+CD25 high T cells in naïve Crohn's disease.
Dig Dis Sci
; 54(10): 2084-93, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19051021
8.
Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells.
JCI Insight
; 3(13)2018 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997289
9.
Regulatory T cells and systemic lupus erythematosus.
Ann N Y Acad Sci
; 1108: 64-75, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17893971
10.
Peptide-based therapy in lupus: promising data.
Adv Exp Med Biol
; 601: 105-12, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17712997
11.
Follicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?
J Immunol Res
; 2016: 5767106, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27635407
12.
Peptide-based immunotherapy of systemic lupus erythematosus.
Autoimmun Rev
; 3(1): 16-24, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14871645
13.
Circulating TFH subset distribution is strongly affected in lupus patients with an active disease.
PLoS One
; 8(9): e75319, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24069401
14.
Novel glycolipid TLR2 ligands of the type Pam2Cys-α-Gal: synthesis and biological properties.
Eur J Med Chem
; 51: 174-83, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22483966
15.
Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor.
PLoS One
; 7(1): e28899, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22247763
16.
Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects.
Arthritis Res Ther
; 11(3): 234, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19591653
17.
Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
Arthritis Rheum
; 58(6): 1751-61, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18512811
18.
Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial.
Arthritis Rheum
; 58(12): 3873-83, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19035498
19.
Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupus.
Arthritis Res Ther
; 9(5): R111, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17963484
20.
Influenza virus-induced type I interferon leads to polyclonal B-cell activation but does not break down B-cell tolerance.
J Virol
; 81(22): 12525-34, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17855528